Drug Detail

Drug Name JNJ 38877605
Trade Name
Drug Descriptions

JNJ 38877605 binds to MET and prevents its activation, resulting in decreased downstream signaling and potentially resulting in increased cell death of MET-overexpressing tumor cells (NCI Drug Dictionary).

DrugClasses MET Inhibitor 51


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Cetuximab + JNJ 38877605 Cetuximab JNJ 38877605 1 0
JNJ 38877605 JNJ 38877605 1 0
JNJ 38877605 + Panitumumab JNJ 38877605 Panitumumab 1 0

Additional content available in CKB BOOST